EBMT NEWSLETTER | November 2017 | Volume 59 - Issue 5

EBMT
Important dates

The EBMT at ASH Annual Meeting

Once again, the EBMT will be actively participating to the 59th American Society of Hematology Meeting that will be held December 9-12, in Atlanta, Georgia, US.

The EBMT will present 48 communications in the different oral or posters sessions.
You will find below the list of these abstracts including title, time and location of presentations. You can click on the title to view the full abstract from the ASH website.

Congratulations to all co-authors and thank you all for your continuous support!

 
Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 50 Years or Older with Severe Aplastic Anaemia: Results from the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research
Result Type: Paper
Number: 2446
Presenter: Carmel Rice
Program: Oral and Poster Abstracts
Session: 508. Bone Marrow Failure: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 2025
Presenter: Eva Gonzalez-Barca
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

In the Era of Chemoimmunotherapy, Relapse Post Autologous Stem Cell Transplantation for Follicular Lymphoma Is Associated with Prolonged Overall Survival. an Analysis By the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 3299
Presenter: Stephen Robinson
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Stem Cell Transplantation for Congenital Dyserythropoietic Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the  European Blood and Marrow Transplantation Group (EBMT)
Result Type: Paper
Number: 4600
Presenter: Maurizio Miano
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Selecting between HLA-Matched Siblings and HLA- Haploidentical Related Donors for Acute Leukemia in the Era of Post-Transplant Cyclophosphamide: The Center for International Blood and Marrow Transplant Registry and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant
Result Type: Paper
Number: 851
Presenter: Tara Robinson
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era
Time and Location:
Monday, December 11, 2017: 4:30 PM-6:00 PM
Bldg C, Lvl 2, C202-C204 (Georgia World Congress Center) 

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Adult Patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in First Complete Remission (CR1): Favorable Outcome of Patients with Negative Minimal Residual Disease (MRD) Status at Transplant. a Report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)
Result Type: Paper
Number: 669
Presenter: Jordi Esteve
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes
Time and Location:
Monday, December 11, 2017: 10:30 AM-12:00 PM
Bldg B, Lvl 3, B312-B314 (Georgia World Congress Center) 

Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Result Type: Paper
Number: 3307
Presenter: Marie Robin
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 595
Presenter: Xavier Poire
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning
Time and Location:
Monday, December 11, 2017: 7:00 AM-8:30 AM
Bldg B, Lvl 3, B312-B314 (Georgia World Congress Center) 

Haploidentical T-Repleted Stem Cell Transplantation (SCT) Has Comparable Survival to 10/10 and 9/10 Unrelated SCT in Poor-Cytogenetics Risk Acute Myeloid Leukemia in First Complete Remission: A Study on Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 852
Presenter: Francesca Lorentino
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era
Time and Location:
Monday, December 11, 2017: 4:30 PM-6:00 PM
Bldg C, Lvl 2, C202-C204 (Georgia World Congress Center) 

Allogeneic Stem Cell Transplantation in  Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 596
Presenter: Marina Diaz Beya
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning
Time and Location:
Monday, December 11, 2017: 7:00 AM-8:30 AM
Bldg B, Lvl 3, B312-B314 (Georgia World Congress Center) 
 
Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 4568
Presenter: Francesco Saraceni
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 273
Presenter: Mohamed Kharfan-Dabaja
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse 
Time and Location:
Saturday, December 9, 2017: 4:00 PM-5:30 PM
Bldg C, Lvl 2, C211-C213 (Georgia World Congress Center) 

KIR- Ligand Mismatching Is Associated with Inferior Survival in Patients with Acute Leukemia Following T-Cell Replete Peripheral-Blood Stem Cell Haplo-Identical Transplantation with Post-Transplant Cyclophosphamide.  a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Result Type: Paper
Number: 3302
Presenter: Avichai Shimoni
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Autoimmune Cytopenias (AIC) Following Allogeneic Haematopoietic Stem Cell Transplant for Acquired Aplastic Anaemia: A Joint Study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 1994
Presenter: Paul Miller
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party
Result Type: Paper
Number: 4576
Presenter: Johannes Schetelig
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Transplantation Outcome By Disease Risk and Donor Type over Time: An Analysis of 100,000 Allogeneic Stem Cell Transplantation on Behalf of the Acute Leukemia Working Party of the EBMT
Result Type: Paper
Number: 668
Presenter: Roni Shouval
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes
Time and Location:
Monday, December 11, 2017: 10:30 AM-12:00 PM
Bldg B, Lvl 3, B312-B314 (Georgia World Congress Center) 

Impact of Donor Type in Patients with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Cell Transplantation after Low-Dose TBI Based Regimen: A Study from the Acute Leukemia Working Party of the EBMT and Eurocord
Result Type: Paper
Number: 2029
Presenter: Frederic Baron
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Variability of Nutritional Practices in Peritransplant Period after Allogeneic Hematopoietic Stem Cell Transplantation: A Survey By the Complications and Quality of Life Working Party of the EBMT
Result Type: Paper
Number: 1954
Presenter: Zinaida Peric
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 
 
Use of Busulfan in Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Adults: A Survey By the Complications and Quality of Life Working Party of the EBMT
Result Type: Paper
Number: 1955
Presenter: Tapani Ruutu
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Outcome of Children Developing Grade III-IV Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Report on Behalf of the EBMT Paediatric Diseases Working Party
Result Type: Paper
Number: 76
Presenter: Alice Bertaina
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology
Time and Location:
Saturday, December 9, 2017: 7:30 AM-9:00 AM
Bldg B, Lvl 3, B308-B309 (Georgia World Congress Center) 
 
Evaluation of Clinical and Morphological Practices in the Diagnosis of Transplant-Associated Microangiopathy: A Study on Behalf of the Complications and Quality of Life Working Party of the EBMT
Result Type: Paper
Number: 1958
Presenter: Ivan Moiseev
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Outcomes of Unrelated Cord Blood Transplantation for Familial Hemophagocytic Lymphohistiocytosis: Risk Factors and Long Term Follow-up. an Analysis on Behalf of Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology Working Party of the EBMT and Inborn Errors Working Party of the EBMT
Result Type: Paper
Number: 2049
Presenter: Juliana Montibeller Furtado E Silva
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study
Result Type: Paper
Number: 3318
Presenter: Annalisa Paviglianiti
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study
Result Type: Paper
Number: 907
Presenter: Bipin Savani
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens 
Time and Location:
Monday, December 11, 2017: 6:15 PM-7:45 PM
Bldg B, Lvl 4, B401-B402 (Georgia World Congress Center) 

The Prognostic Impact of the Donor/Recipient CMV Serostatus in Patients with Different Chronic Hematological Disorders after Allogeneic Hematopoietic Stem Cell Transplantation: A Report from the Infectious Diseases Working Party of EBMT
Result Type: Paper
Number: 1961
Presenter: Martin Schmidt-Hieber
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Donor EBV-Positive Serostatus Increases the Risk of Chronic GvHD in Patients with Myeloid and Lymphoid Malignancies Other Than Acute Leukemia: Infectious Diseases Working Party EBMT Study
Result Type: Paper
Number: 4488
Presenter: Jan Styczynski
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III
Time and Location:
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Favorable Long-Term Outcomes after Allogeneic Transplantation for Elderly Patients with Myelodysplastic Syndromes: A Report from the Chronic Malignancies Working Party of EBMT
Result Type: Paper
Number: 4577
Presenter: Johannes Schetelig
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties
Result Type: Paper
Number: 3273
Presenter: Peter Dreger
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

An EBMT Analysis of Matched Sibling, Mismatched Family or Matched Unrelated Donors for Allogeneic Stem Cell Transplants in MDS
Result Type: Paper
Number: 4593
Presenter: Kavita Raj
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Haplo-Identical Stem Cell Transplantation for Patients with Multiple Myeloma Who Relapsed after Autografting. a Study from the Cmwp of EBMT
Result Type: Paper
Number: 2046
Presenter: Nicolaus Kroeger
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

The Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: An Analysis By the EBMT Complications and Quality of Life WP
Result Type: Paper
Number: 3324
Presenter: Madan Jagasia
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)
 
G-CSF Vs Haematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia with ELANE Mutation: Role of G-CSF Dose. a Retrospective Controlled Study on Behalf of Saawp (Severe Aplastic Anemia Working Party) of the EBMT,  of the Stem Cell Transplant for Immunodeficiency Group in Europe (SCETIDE), of the Severe Chronic Neutropenia French Registry (SCNFR) and Italian Neutropenia Registry (INR)
Result Type: Paper
Number: 2267
Presenter: Francesca Fioredda
Program: Oral and Poster Abstracts
Session: 201. Granulocytes, Monocytes, and Macrophages: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Transplant Outcome for Secondary Acute Myeloid Leukemia Based on Prior Hematological Disease or Solid Malignancy - on Behalf of the ALWP of the EBMT
Result Type: Paper
Number: 3320
Presenter: Bipin Savani
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of the EBMT
Result Type: Paper
Number: 2028
Presenter: Martin Carre
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 
 
Impact of In Vivo T-Cell Depletion in Patients with Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Registry Study from the Chronic Malignancies Working Party of the EBMT
Result Type: Paper
Number: 520
Presenter: Edouard Forcade
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: GVH and GVL
Time and Location:
Sunday, December 10, 2017: 4:30 PM-6:00 PM
Bldg C, Lvl 2, C211-C213 (Georgia World Congress Center) 

The Use of Anti-Thymocyte Globulin Is Associated with Decreased Risk of Chronic Graft-Versus-Host Disease without Impact on Survival after Allogeneic Peripheral Blood Stem Cell Transplantation for Adults with Philadelphia-Positive Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT
Result Type: Paper
Number: 1971
Presenter: Sebastian Giebel
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC
Result Type: Paper
Number: 4564
Presenter: Florent Malard
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster III
Time and Location:
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 273
Presenter: Mohamed Kharfan-Dabaja
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse 
Time and Location:
Saturday, December 9, 2017: 4:00 PM-5:30 PM
Bldg C, Lvl 2, C211-C213 (Georgia World Congress Center) 

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Siblings Versus Unmanipulated Haploidentical Donors in Relapsing or Refractory Acute Myeloid Leukemia: A Retrospective Study from the ALWP of the EBMT
Result Type: Paper
Number: 2027
Presenter: Giorgia Battipaglia
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Outcomes of Graft Failures after Umbilical Cord Blood Transplantation in Acute Leukemia: A Study from Eurocord and the Acute Leukemia Working Party of the EBMT
Result Type: Paper
Number: 661
Presenter: Frederic Baron
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants
Time and Location:
Monday, December 11, 2017: 10:30 AM-12:00 PM
Bldg C, Lvl 2, C202-C204 (Georgia World Congress Center) 

Second Allogeneic Hematopoietic Stem Cell Transplantation for Post-Transplant Relapsed Acute Leukemia in Children - an EBMT PDWP Retrospective Study
Result Type: Paper
Number: 912
Presenter: Isaac Yaniv
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens 
Time and Location:
Monday, December 11, 2017: 6:15 PM-7:45 PM
Bldg B, Lvl 4, B401-B402 (Georgia World Congress Center) 

Variability of Nutritional Practices in Peritransplant Period after Allogeneic Hematopoietic Stem Cell Transplantation: A Survey By the Complications and Quality of Life Working Party of the EBMT
Result Type: Paper
Number: 1954
Presenter: Zinaida Peric
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Indications for Hematopoietic Stem Cell Transplantation in Patients with Waldenstrom’s Macroglobulinemia: A Consensus Project of the EBMT Lymphoma Working Party (LWP)/ European Consortium for Waldenstrom's Macroglobulinemia (ECWM)/International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Result Type: Paper
Number: 2026
Presenter: Charalampia Kyriakou
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Use of Busulfan in Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Adults: A Survey By the Complications and Quality of Life Working Party of the EBMT
Result Type: Paper
Number: 1955
Presenter: Tapani Ruutu
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I
Time and Location:
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Outcome of Children Developing Grade III-IV Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Report on Behalf of the EBMT Paediatric Diseases Working Party
Result Type: Paper
Number: 76
Presenter: Alice Bertaina
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology
Time and Location:
Saturday, December 9, 2017: 7:30 AM-9:00 AM
Bldg B, Lvl 3, B308-B309 (Georgia World Congress Center) 

Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities
Result Type: Paper
Number: 3398
Presenter: Jan Styczynski
Program: Oral and Poster Abstracts
Session: 902. Health Services Research—Malignant Conditions: Poster II
Time and Location:
Sunday, December 10, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center) 

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? – a Multicenter EBMT-PDWP Study
Result Type: Paper
Number: 911
Presenter: Andre Willasch
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens 
Time and Location:
Monday, December 11, 2017: 6:15 PM-7:45 PM
Bldg B, Lvl 4, B401-B402 (Georgia World Congress Center) 

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT
Result Type: Paper
Number: 215
Presenter: Annalisa Ruggeri
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention
Time and Location:
Saturday, December 9, 2017: 2:00 PM-3:30 PM
Bldg B, Lvl 3, B308-B309 (Georgia World Congress Center)
Bookmark and Share